The University of Chicago Header Logo

Connection

Stephen Hanauer to Glucocorticoids

Back to Details
This is a "connection" page, showing publications Stephen Hanauer has written about Glucocorticoids.
Stephen Hanauer
Connection Strength
1.785
Glucocorticoids
  1. Optimizing conventional therapies for inflammatory bowel disease. Curr Gastroenterol Rep. 2009 Dec; 11(6):496-503.
    View in: PubMed
    Score: 0.302
  2. Semantics. Nat Clin Pract Gastroenterol Hepatol. 2008 Feb; 5(2):59.
    View in: PubMed
    Score: 0.266
  3. Parallel universes. Nat Clin Pract Gastroenterol Hepatol. 2007 Aug; 4(8):411.
    View in: PubMed
    Score: 0.257
  4. Steroids as recreational drugs. Nat Clin Pract Gastroenterol Hepatol. 2006 Jun; 3(6):295.
    View in: PubMed
    Score: 0.237
  5. New steroids for IBD: progress report. Gut. 2002 Aug; 51(2):182-3.
    View in: PubMed
    Score: 0.181
  6. In vitro sensitivity assays and clinical response to glucocorticoids in patients with inflammatory bowel disease. J Crohns Colitis. 2014 Nov; 8(11):1539-47.
    View in: PubMed
    Score: 0.104
  7. Long-term treatment of patients with a history of ulcerative colitis who develop gastritis and pan-enteritis after colectomy. J Clin Gastroenterol. 2013 Jan; 47(1):52-7.
    View in: PubMed
    Score: 0.093
  8. Medical therapy for ulcerative colitis 2004. Gastroenterology. 2004 May; 126(6):1582-92.
    View in: PubMed
    Score: 0.051
  9. Treatment of inflammatory bowel disease: safety and tolerability issues. Am J Gastroenterol. 2003 Dec; 98(12 Suppl):S18-23.
    View in: PubMed
    Score: 0.050
  10. Medical therapy to reduce postoperative Crohn's disease recurrence. Am J Gastroenterol. 2000 May; 95(5):1139-46.
    View in: PubMed
    Score: 0.039
  11. A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis. Am J Gastroenterol. 2000 May; 95(5):1263-76.
    View in: PubMed
    Score: 0.039
  12. Cyclosporin for severe ulcerative colitis: a user's guide. Am J Gastroenterol. 1997 Sep; 92(9):1424-8.
    View in: PubMed
    Score: 0.032
  13. New therapeutic approaches. Gastroenterol Clin North Am. 1995 Sep; 24(3):523-40.
    View in: PubMed
    Score: 0.028
  14. Vedolizumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2013 Aug 22; 369(8):699-710.
    View in: PubMed
    Score: 0.024
  15. Vedolizumab as induction and maintenance therapy for Crohn's disease. N Engl J Med. 2013 Aug 22; 369(8):711-21.
    View in: PubMed
    Score: 0.024
  16. Adalimumab sustains steroid-free remission after 3 years of therapy for Crohn's disease. Aliment Pharmacol Ther. 2011 Aug; 34(3):306-17.
    View in: PubMed
    Score: 0.021
  17. Defining the optimal response criteria for the Crohn's disease activity index for induction studies in patients with mildly to moderately active Crohn's disease. Am J Gastroenterol. 2008 Dec; 103(12):3123-31.
    View in: PubMed
    Score: 0.018
  18. A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators. N Engl J Med. 2000 Jun 01; 342(22):1627-32.
    View in: PubMed
    Score: 0.010
  19. Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study Group. Gastroenterology. 1999 Sep; 117(3):527-35.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.